Skip to content
sellWeak10b5-1 plan

Vivek Jain sold $2.1M of ICUI

Chairman and CEO at ICU MEDICAL INC/DE. 12,000 shares at an average of $171.84, traded Nov 1, 2024, filed Nov 4, 2024.

Warning score
20
Value
$2.1M
12,000 shares
Holdings after
104,593
-10% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet

Score components

  • Role
    CEO
    +25
  • Trade size
    $2.1M at market
    +25
  • Share of holdings sold
    Sold 10% of holdings
    +5
  • Cluster
    No other insider selling within 14 days
    0
  • Exercise and sell
    Shares came from an option exercise in the same filing
    -15
  • 10b5-1 plan
    Pre-scheduled under a 10b5-1 plan
    -20

What happened after comparable sells

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

This signal so far: 1m -8.9%, 3m -7.7%, 6m -20.9%.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

ICUIOct 9, 2026 · close 160.32
Since filing Nov 4, 2024: -6.8%SPY +39.8% · excess -46.6%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0001410442-24-000007, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Nov 1, 2024MOption exercise
Common Stock10b5-1
+12,000$88.76$1.1M116,593Nov 4, 2024
Nov 1, 2024SOpen-market sale
Common Stock10b5-1
-4,228$170.75$722k112,365Nov 4, 2024
Nov 1, 2024SOpen-market sale
Common Stock10b5-1
-4,147$171.91$713k108,218Nov 4, 2024
Nov 1, 2024SOpen-market sale
Common Stock10b5-1
-2,386$172.76$412k105,832Nov 4, 2024
Nov 1, 2024SOpen-market sale
Common Stock10b5-1
-1,239$173.60$215k104,593Nov 4, 2024
Nov 1, 2024MOption exercise
Non-Qualified Stock Option (right to buy)derivative10b5-1
-12,000$0.00$013,373Nov 4, 2024

Related signals

Other insiders at ICU MEDICAL INC/DE and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
30Weak
ICUIsell 210b5-1
ICU MEDICAL INC/DE
Virginia Ruth Sanzone
VP, General Counsel
$819k
4,856 shares
-25%
40Moderate
ICUIsell 210b5-1
ICU MEDICAL INC/DE
Brian Michael Bonnell
Chief Financial Officer
$1.1M
6,381 shares
-10%
45Moderate
ICUIbuy 2
ICU MEDICAL INC/DE
David C. Greenberg
director
$152k
1,200 shares
+18%
82Strong
ICUIbuy 2
ICU MEDICAL INC/DE
Vivek Jain
Chairman and CEO
$2.5M
21,929 shares
+20%
40Moderate
ICUIsell 3
ICU MEDICAL INC/DE
Virginia Ruth Sanzone
VP, General Counsel
$94k
700 shares
-10%
65Notable
ICUIsell 5
ICU MEDICAL INC/DE
Christian B. Voigtlander
Chief Operating Officer
$1.3M
9,930 shares
-95%
65Notable
ICUIsell 5
ICU MEDICAL INC/DE
Christian B. Voigtlander
Chief Operating Officer
$1.3M
9,918 shares
-107%
65Notable
ICUIsell 5
ICU MEDICAL INC/DE
Christian B. Voigtlander
Chief Operating Officer
$1.3M
9,788 shares
-123%
44Moderate
ICUIsell 5
ICU MEDICAL INC/DE
Elisha W Finney
director
$83k
600 shares
-16%
65Notable
ICUIsell 5
ICU MEDICAL INC/DE
Christian B. Voigtlander
Chief Operating Officer
$1.5M
11,110 shares
-140%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Vivek Jain sold $2.1M of ICUI | InsiderTell